Diagnosis & Early DetectionA New Tool for Ketone Monitoring: What the FDA Approval Means for Type 1 DiabetesResearch, trials, devices, and safety notices — labeled by evidence strength so you can tell solid science from hype.
1486 evidence-labeled articles across 6 topics
New clinical guidelines aim to identify people in the autoimmune stage of Type 1 diabetes years before they develop symp…
Read →
A new clinical trial found that automated insulin delivery systems help pregnant women with type 1 diabetes spend more t…
Read →
A new study from Japan suggests that adults with Type 1 diabetes who follow low-carbohydrate eating patterns—especially…
Read →The FDA recently approved the first device that continuously monitors both glucose and ketones, offering people with Typ…
Read →
Researchers discovered a patient initially diagnosed with Type 1 diabetes actually had a rare genetic form called digeni…
Read →
Scientists are investigating whether GLP-1 receptor agonist medications—already approved for type 2 diabetes and obesity…
Read →Pulled from official registries and public research sources, then labeled by evidence strength before publication.
Saved on this device only. Matching items rise on Today. No health profile required.
33 items from 4 live sources. Feed checked Oct 19, 2026, 7:17 PM GMT-5.
Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues: inoperable pump at setup, lack of protection for moisture exposur... Action: On 08/20/2026, Technical Support called affected customers to inform that, MiniMed identified an issue in which certain MiniMed...
RECRUITING, PHASE3. Interventions: Stem Cell Educator therapy. Locations: Paramus, New Jersey, United States | Paramus, New Jersey, United States. Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals worldwide have T1D, and incidence increases annually. Several recent clinical trials point to the need for an approach that produces comprehensive immune modulation at both...
RECRUITING, PHASE1, PHASE2. Interventions: VV-14300. Locations: Toronto, Canada | Christchurch, New Zealand. This study is testing VV-14300 in adults with long-standing type 1 diabetes (T1D) whose blood sugar is not well controlled despite using an automated insulin delivery (AID) system. VV-14300 is an investigational gene therapy that is injected into muscle and is designed to help remove excess sugar from the blood.
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P... Action: On 07/16/2026, an "URGENT MEDICAL DEVICE CORRECTION" communication was sent via certified mail to customers informing them that a...
RECRUITING, PHASE2. Interventions: Cyclosporin, ILT101, Placebo. Locations: Paris, France. Type 1 diabetes (T1D) is caused by the destruction of insulin-producing cells by effector T cells (Teffs), due to a deficiency of regulatory T cells (Tregs). Ciclosporin effectively blocks the Teffs and controls diabetes, but cannot be considered as a long-term treatment. Low-dose interleukin-2 (ld IL-2) activates and expands Tregs in humans. Hence, Ld IL-2 in patie...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
For MiniMed Go app version 1.0.0 and 1.1.0, when the Set day and night is turned OFF and missed dose or Correct high glucose alerts are enabled, the associated alerts will not be triggered during the nighttime. This could result in missed rapid-acting insulin doses without the user s knowledge, and may lead to delayed therapy and an increased risk of hyperglycemia. Action: On 6/16/2026 In-App Push Notifications were sent to customers entitled, Important Field Safety Corrective Action required on your MiniMed Go ap...
A software anomaly can occur when the pump is paired with the Instinct sensor. Under certain circumstances, the pump unexpectedly stops delivering insulin and displays two error messages back-to-back: Pump Error 53 followed immediately by Pump Error 23. Insulin delivery will stop which may lead to delayed therapy and an increased risk of hyperglycemia or diabetic ketoacidosis... Action: On 5/27/2026, field safety notices were emailed to customers who were asked to do the following: 1) Update insulin pump software...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of in... Action: Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consig...
Daily briefings, device safety watches, trial roundups, and research notes — each linked back to original sources.
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.
A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.
A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.
medscape.com
New clinical guidelines aim to identify people in the autoimmune stage of Type 1 diabetes years before they develop symptoms. The framework standardizes screening and monitoring to catch the disease earlier and improve long-term outcomes.
GlobeNewswire News Room
The experimental immunotherapy, designed to modify disease progression in newly diagnosed Type 1 diabetes, has been granted expedited FDA review status. The move reflects regulatory recognition of an unmet medical need in the Type 1 diabetes community.
Greater Northwest Chapter
Several investigational treatments are being tested in active studies across the Pacific Northwest and beyond. Here's what you need to know about participating in Type 1 diabetes research.
prnewswire.com
The inaugural Breakthrough T1D Clinical & Research Congress brought together clinicians, scientists, and people with lived T1D experience to discuss advances across immunotherapy, technology, and islet cell approaches. Experts emphasized the importance of connecting research discoveries to real clinical care and patie…
New Shorts daily on YouTube and TikTok
New Framework Aims to Catch Type 1 Diabetes Earlier Through Screening
New Framework Aims to Catch Type 1 Diabetes Earlier Through Screening
What New Pancreas Studies Reveal About How Type 1 Diabetes Develops
What New Pancreas Studies Reveal About How Type 1 Diabetes Develops
The Hidden Weight of Type 1 Diabetes: Understanding Distress Across Age and Mental Health
The Hidden Weight of Type 1 Diabetes: Understanding Distress Across Age and Mental Health
LADA: When Type 2 Diagnosis Masks an Autoimmune Condition
LADA: When Type 2 Diagnosis Masks an Autoimmune Condition
First Large Study in Japan Identifies Early Signs of Type 1 Diabetes in Relatives
First Large Study in Japan Identifies Early Signs of Type 1 Diabetes in Relatives
How You Spend Your 24 Hours May Affect Blood Sugar Swings in Type 1 Diabetes
How You Spend Your 24 Hours May Affect Blood Sugar Swings in Type 1 Diabetes
When Baby Screening for Type 1 Diabetes May Show False Positives: What Parents Should Know
When Baby Screening for Type 1 Diabetes May Show False Positives: What Parents Should Know
When Type 1 Diabetes and Celiac Disease Occur Together, Antibody Recovery Takes Longer
When Type 1 Diabetes and Celiac Disease Occur Together, Antibody Recovery Takes Longer
Updated daily from ClinicalTrials.gov
Showing 6 of 8 programs tracked
Track all 8 programs →Chapter 5 — Age 17
“Closing in on seventeen, here's the short version of everything the younger me needed to hear.”
Closing in on seventeen, here's the short version of everything the younger me needed to hear.
Brooke's chapters are personal lived experience shared to make people feel less alone. They are not medical advice and do not describe a treatment plan. Talk to your own care team about your numbers, devices, and decisions.
If FDA, MedWatch, or a manufacturer issues a relevant CGM, pump, app, insulin, or glucagon alert, it should bypass the normal feed and hit the family alert lane first.
Medtronic MiniMed, Inc.
Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues: inoperable pump at setup, lack of protection for moisture exposur... Action: On 08/20/2026, Technical Support called affected customers to inform that, MiniMed identified an issue in which certain MiniMed...
Open alertTandem Diabetes Care, Inc.
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P... Action: On 07/16/2026, an "URGENT MEDICAL DEVICE CORRECTION" communication was sent via certified mail to customers informing them that a...
Open alertMedtronic MiniMed, Inc.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Open alertMedtronic MiniMed, Inc.
Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Action: On 7/13/2026, field safety notices were sent to customers asking them to do the following: 1) Stop using the loaner pump and contact the firm to arrange for loaner pump return. 2) Contact your Healthcare Professional (H...
Open alert